Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.
View Top Employees from Ziopharm OncologyWebsite | https://alaunos.com/ |
Ticker | ZIOP |
Revenue | $6 million |
Employees | 41 (41 on RocketReach) |
Founded | 2005 |
Address | 8030 El Rio St, Houston, Texas 77030, US |
Phone | (617) 259-1970 |
Fax | (617) 241-2855 |
Technologies |
JavaScript,
HTML,
PHP
+38 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Manufacturing & Research, Science and Engineering, Healthcare, Genetics, Health Care, Pharmaceutical, Therapeutics |
Web Rank | 2 Million |
Keywords | Ytb323, Ziop Investor Relations, Ziopharm Oncology, Ziopharm, Inducible Gene Therapy |
Competitors | AVEO Oncology, G1 Therapeutics, Inc., Kronos Bio, MIS.CARBONART, TYME Technologies Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325414 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 541711 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Ziopharm Oncology employee's phone or email?
The Ziopharm Oncology annual revenue was $6 million in 2023.
Haroon Hashmi is the Vice President, Regulatory Affairs of Ziopharm Oncology.
41 people are employed at Ziopharm Oncology.
Ziopharm Oncology is based in Houston, Texas.
The NAICS codes for Ziopharm Oncology are [325414, 32541, 325, 541711, 3254, 541, 5417, 32, 54171, 54].
The SIC codes for Ziopharm Oncology are [283, 28].